India launched the Phenome National Conclave on Longitudinal Cohort Studies, called Cohort Connect 2025.
It was inaugurated at the Council of Scientific and Industrial Research–Institute of Minerals and Materials Technology (CSIR–IMMT) in Bhubaneswar.
The initiative aims to become India’s largest evidence-based study examining genetic, lifestyle, and environmental drivers of major diseases.
The launch highlighted the rising national burden of metabolic disorders such as diabetes and their related complications.
India has already sequenced nearly 10,000 human genomes through CSIR and the Department of Biotechnology, with work progressing toward one million genome sequences.
The programme will support long-term cohort studies to generate India-specific data for preventive and precision-medicine approaches.